George A. Syrogiannopoulos (Greece)

University of Thessaly, School of Medicine Department of Paediatrics
Dr. George A. Syrogiannopoulos is at present Emeritus Professor of Paediatrics in the School of Medicine of the University of Thessaly and senior staff member at the Infectious Diseases Research Laboratory, of the Department of Paediatrics in Larissa, Greece. Dr. Syrogiannopoulos’ research interest has focused on respiratory, osteoarticular and central nervous system infections. He has published extensively in peer-reviewed international journals and has participated in round tables in several international Meetings. He is currently member of the International Editorial Boards of the Pediatric Infectious Disease Journal and ESPID Reviews and Reports (‘purple pages’) in the Pediatric Infectious Diseases Journal, and a regular reviewer in numerous international journals. He has been a long-standing active member of ESPID serving as Board Member and Deputy President (1998-1999) and organized the 17th Annual ESPID Meeting/Joint Meeting with the Pediatric Infectious Diseases Society of America held in Heraklion – Crete, Greece in 1999. From 2003 to 2007 he served as member and subsequently as Chairman (2007-2013) of the Committee of Scientific Affairs and Awards of ESPID, and of the Research Networking Committee of ESPID during 2016-2019. Dr. Syrogiannopoulos is an elected Board Member of the Hellenic Society for Paediatric Infectious Diseases since December 2018.

Author Of 5 Presentations

Forgotten Wisdom – The Most Influential Studies You Need To Have Heard Of

Date
Wed, 11.05.2022
Session Time
17:15 - 18:15
Session Type
Plenary Symposium
Room
ALEXANDRA TRIANTI HALL
Lecture Time
17:33 - 17:41

Expert

Date
Fri, 13.05.2022
Session Time
07:30 - 08:20
Session Type
Meet The Experts
Room
DIMITRIS MITROPOULOS HALL
Lecture Time
07:30 - 07:30

Welcome and Introduction

Date
Mon, 09.05.2022
Session Time
13:45 - 15:15
Session Type
Sponsored Symposium
Room
ALEXANDRA TRIANTI HALL
Lecture Time
13:45 - 13:50

CHARACTERISTICS OF CHILDREN HOSPITALIZED WITH MIS-C DURING THREE PANDEMIC WAVES IN GREECE

Date
Wed, 11.05.2022
Session Time
13:40 - 15:10
Session Type
Joint Symposium
Room
BANQUETING HALL
Lecture Time
14:50 - 14:58

Abstract

Backgrounds:

The Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but potentially severe complication of COVID-19.

Methods

This is a retrospective observational study of children aged <18 years hospitalized with MIS-C in 10 tertiary hospitals in Greece during three pandemic waves characterized by different SARS-CoV-2 variant: i. from August 2020 to January 2021 (EU1-B.1.177), ii. from February 2021 to July 2021 (Alpha-B.1.1.7) and iii. from August 2021 to December 2021 (Delta-B.1.617.2). The aim of the study was to document the incidence over time, clinical characteristics and outcome of children admitted with MIS-C in Greek hospitals during the COVID-19 pandemic.

Results:

table 1.jpg

In total, 119 patients were included, 91.6% (109/119) met the WHO criteria of MIS-C diagnosis: 26.9% (32/119), 39.5% (47/119) and 33.6% (40/119) were hospitalized during the 1st, 2nd, and 3rd study period, respectively. Demographic and clinical characteristics are shown in Table 1. No cases were found before October 2020. The incidence of MIS-C significantly decreased over the three waves from 3.3/1000 to 0.25/1000 confirmed COVID-19 cases (P <0.0001). No other significant difference was observed in the clinical manifestations and disease severity of children hospitalized with MIS-C over the three waves.

Conclusions/Learning Points:

This study indicates that the incidence of MIS-C may vary according to the predominant variant. Outcome remains favourable regardless of the variant leading to MIS-C. Larger studies are needed to clarify if clinical characteristics and/or disease severity may differ, as well.

Hide

Presenter of 4 Presentations

Forgotten Wisdom – The Most Influential Studies You Need To Have Heard Of

Date
Wed, 11.05.2022
Session Time
17:15 - 18:15
Session Type
Plenary Symposium
Room
ALEXANDRA TRIANTI HALL
Lecture Time
17:33 - 17:41

Expert

Date
Fri, 13.05.2022
Session Time
07:30 - 08:20
Session Type
Meet The Experts
Room
DIMITRIS MITROPOULOS HALL
Lecture Time
07:30 - 07:30

Welcome and Introduction

Date
Mon, 09.05.2022
Session Time
13:45 - 15:15
Session Type
Sponsored Symposium
Room
ALEXANDRA TRIANTI HALL
Lecture Time
13:45 - 13:50

Moderator of 2 Sessions

Session Type
Sponsored Symposium
Date
Mon, 09.05.2022
Session Time
13:45 - 15:15
Room
ALEXANDRA TRIANTI HALL
Session Description
Pneumococcal Disease in Children: Impact of Pneumococcal Conjugate Vaccines (PCV) and Outlook for the Future – Supported by Pfizer.

Session Description:

Join us as experts discuss the changing state of pneumococcal disease in a symposium covering: • Impact of PCVs on pediatric pneumococcal disease in Europe and around the world • Importance of pneumococcal vaccination in high-risk pediatric populations • Changes in pneumococcal disease following a global pandemic

Session Type
Oral Presentations Session
Date
Wed, 11.05.2022
Session Time
10:00 - 11:02
Room
BANQUETING HALL

Facilitator Of

Session Type
Sponsored Symposium
Date
Mon, 09.05.2022
Session Time
13:45 - 15:15
Room
ALEXANDRA TRIANTI HALL
Session Description
Pneumococcal Disease in Children: Impact of Pneumococcal Conjugate Vaccines (PCV) and Outlook for the Future – Supported by Pfizer.

Session Description:

Join us as experts discuss the changing state of pneumococcal disease in a symposium covering: • Impact of PCVs on pediatric pneumococcal disease in Europe and around the world • Importance of pneumococcal vaccination in high-risk pediatric populations • Changes in pneumococcal disease following a global pandemic

Poster Author Of 4 e-Posters